🔎 Trials Near Me

Hjem › Prostatakreft › Delaware

Kliniske studier for Prostatakreft i Delaware

10 studier for Prostatakreft søker deltakere på steder i Delaware.

Byer i Delaware

Offisiell studietekst (engelsk)

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • Medical Oncology Hematology Consultants, Newark
RekruttererFase 1/2
Alder 12 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT04585750

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

  • Helen F Graham Cancer Center, Newark
  • Medical Oncology Hematology Consultants PA, Newark
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 2. okt. 2026 · NCT07200830

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

  • Beebe South Coastal Health Campus, Millville
  • Helen F Graham Cancer Center, Newark
  • Medical Oncology Hematology Consultants PA, Newark
  • og 1 flere
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06632977

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

  • Medical Oncology Hematology Consultants Helen F Graham Cancer Center, Newark
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 22. sep. 2026 · NCT07213674

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  • Helen F Graham Cancer Center, Newark
  • Medical Oncology Hematology Consultants PA, Newark
  • Christiana Care Health System-Wilmington Hospital, Wilmington
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 10. sep. 2026 · NCT05946213

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

  • Beebe Medical Center, Lewes
  • Beebe South Coastal Health Campus, Millville
  • Helen F Graham Cancer Center, Newark
  • og 4 flere
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 14. jul. 2026 · NCT06592924

Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

  • Beebe Medical Center, Lewes
  • Beebe South Coastal Health Campus, Millville
  • Helen F Graham Cancer Center, Newark
  • og 4 flere
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 22. jan. 2026 · NCT06470243

Vitamin D for Prostate Endocrine Therapy

  • Helen F Graham Cancer Center, Newark
  • Medical Oncology Hematology Consultants PA, Newark
RekruttererFase 3
Alder 50 og eldre · Menn · Oppdatert 15. jan. 2026 · NCT05838716

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Newark
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

  • Helen F Graham Cancer Center, Newark
  • Christiana Care Health System-Christiana Hospital, Newark
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 11. sep. 2025 · NCT03678025

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.